2012 French open finalist, Sara Errani has received a two month ban from tennis after testing positive to banned substance – letrozole in February.
The ban was sanctioned by the International Tennis Federation on Monday. The 98th ranked player has since admitted to charge at a hearing before an Independent Tribunal in April.
Tennis Anti-Doping Programme: Sara Errani has been found to have committed an Anti-Doping Rule Violation https://t.co/ikw9kfNMkE pic.twitter.com/7rjfMme4Vf
— ITF (@ITF_Tennis) August 7, 2017
According to ITF ” Ms Errani provided a urine sample on 16 February 2017 as part of an Out-of-Competition test under the Programme. That sample was sent to the WADA-accredited laboratory in Montreal, Canada for analysis, and was found to contain letrozole, which is an aromatase inhibitor that is included under section S4 (Hormone and Metabolic Modulators) of the 2017 WADA Prohibited List, and therefore is also prohibited under the Programme.”
Therefore, the Italian will be ineligible to play tennis for 2 months commencing on the 3rd of August 2017, as well as forfeiting all the ranking points and prize money she’s accrued between February and July.
Errani’s ban runs till the midnight of 2nd October 2017, her last tournament was at the Citi open in Washington DC where she lost to Oceana Dodin in the second round.
